{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-211859","form_type":"8-K","ticker":"VIR","cik":"0001706431","company_name":"Vir Biotechnology, Inc.","filed_at":"2022-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.724582+00:00","generated_at":"2026-06-24T04:16:45.112734+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Vir Biotechnology delays Q2 2022 earnings release to Aug 9, 2022 to finalize results","bullets":["Company will issue Q2 2022 earnings release on August 9, 2022 after market close.","Delay allows additional time to finalize financial results for the quarter ended June 30, 2022.","Quarterly Report on Form 10-Q remains scheduled for filing on or before its due date of August 9, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-211859","json":"https://secwatch.observer/filing/0001193125-22-211859.json","markdown":"https://secwatch.observer/filing/0001193125-22-211859.md","text":"https://secwatch.observer/filing/0001193125-22-211859.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1706431/000119312522211859/0001193125-22-211859-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1706431/000119312522211859/d389021d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T04:16:45.112734+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}